USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.24+0.51 (+4.01%)
Close on Nov 13, 2026Market cap $244.63MP/E –Yield –
USANA Health Sciences EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
USANA Health Sciences's EV/EBITDA was 2.2× on Nov 11, 2026, against 3.1× a year earlier. Over the last 5 years it ranged from 2.2× to 8.6×, with a median of 5.3×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.2× | −0.9 |
| 2025 | Dec 31, 2025 | 3.1× | −0.3 |
| 2024 | Dec 31, 2024 | 3.3× | −3.5 |
| 2023 | Dec 29, 2023 | 6.9× | +0.9 |
| 2022 | Dec 30, 2022 | 6.0× | −2.6 |
| 2021 | Dec 31, 2021 | 8.5× | +1.2 |
| 2020 | Dec 31, 2020 | 7.4× | −1.8 |
| 2019 | Dec 31, 2019 | 9.2× | −4.4 |
| 2018 | Dec 31, 2018 | 13.5× | +2.5 |
| 2017 | Dec 29, 2017 | 11.0× | +2.2 |
| 2016 | Dec 30, 2016 | 8.8× | −1.1 |
| 2015 | Dec 31, 2015 | 9.9× | +0.2 |
| 2014 | Dec 31, 2014 | 9.7× | +2.3 |
| 2013 | Dec 31, 2013 | 7.5× | +3.4 |
| 2012 | Dec 31, 2012 | 4.1× | −0.9 |
| 2011 | Dec 30, 2011 | 5.0× | −6.3 |
| 2010 | Dec 31, 2010 | 11.3× | – |
See a number that looks wrong?